The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains
about
Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosisReceptor specificity of the fibroblast growth factor familyThe distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesisThe Fanconi anemia polypeptide FACC is localized to the cytoplasmA functional isoform of the human granulocyte/macrophage colony-stimulating factor receptor has an unusual cytoplasmic domainGranulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinasesIsolation of interleukin 2-induced immediate-early genesIdentification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropeniaMolecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamilyDissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domainJAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosisMultiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cellsFunctional regions of the mouse interleukin-10 receptor cytoplasmic domainActivating point mutations in the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of beta subunit dimerization and cell type-specific molecules in signallingThe SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptorThe prolactin receptor and severely truncated erythropoietin receptors support differentiation of erythroid progenitorsRole of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell proliferation and phosphatidylinositol 3-kinase activityThe c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-MplDUB-1, a deubiquitinating enzyme with growth-suppressing activityJAK2 V617F in myeloid disorders: what do we know now, and where are we headed?Negative signaling in health and disease.Abnormalities of cytokine receptor signalling contributing to diseases of red blood cell production.Erythropoietin and erythropoietin receptor.Stoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras.Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells.Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosisDna damage-induced G(1) arrest in hematopoietic cells is overridden following phosphatidylinositol 3-kinase-dependent activation of cyclin-dependent kinase 2The human granulocyte-macrophage colony-stimulating factor receptor is capable of initiating signal transduction in NIH3T3 cells.Both the polycythemia- and anemia-inducing strains of Friend spleen focus-forming virus induce constitutive activation of the Raf-1/mitogen-activated protein kinase signal transduction pathwayAnalysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation.Stat5 signaling specifies basal versus stress erythropoietic responses through distinct binary and graded dynamic modalities.Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle.Functional characterization of a chimeric soluble Fas ligand polymer with in vivo anti-tumor activityMouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor geneSurvival and proliferative roles of erythropoietin beyond the erythroid lineage.Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases.Mutational analysis of a critical signaling domain of the human interleukin 4 receptor.PCR: catching the next wave.The human erythropoietin receptor.
P2860
Q24308841-2AD48E99-A420-400D-9921-8E2FD707EE72Q24320178-28650ED0-7059-4AF7-A71F-E6406FF91F40Q24550897-3A8C938E-9DA8-409C-A121-5A0567893E8DQ24561493-020B25C3-0808-449C-B6FC-88B9DE8ED3CBQ24562886-D333E7C6-C735-4C6D-BB02-B5BC99385565Q24563242-3F4A6C72-3A49-4F28-BB53-18CDC15C99A5Q24563249-D598DB81-F508-465E-971A-C26B7C030A21Q24563273-7CA51527-E612-4543-A3EB-887DCD7DBBE0Q24564819-63CAC05A-A25D-4600-AB7C-B0C86D7FA277Q24564909-309E2FEE-E850-46C5-8828-7C7376EEA483Q24609999-A1F69C08-6EE2-4605-8C8F-A284E6E5BDE0Q24615593-B79B0AED-05BB-4D06-BFEA-211FFE9E07C1Q24651335-64BB7761-9412-4EA1-95CA-437F84B7740EQ28117340-E2B49B1C-5298-44B3-84AA-B269050A287AQ28144156-011AC953-B680-44DC-A83B-F5C40263FB70Q28238908-A118AA2D-18CA-45EE-B7C6-314E813734E3Q28238969-EC20E27E-0837-4BBE-A62F-AB8E1D3C1228Q28287528-107802FC-7FFA-40F8-8D33-54BF0FF8FA34Q28592240-2DA232F8-38A7-4491-B477-AECDA1144C4BQ33341856-CAA865C2-A1D2-4747-8C0F-4A0C79244E4AQ33664134-0C412244-B896-4F91-A869-C8501CAAC018Q33708686-8BA64C3F-4914-44F9-B9BF-1705483AAB55Q33737971-1965F9A0-ECC7-4288-BDDF-C5437757F124Q33771375-30C3BDAA-418B-4BB1-AE1F-360E7E94BBB6Q33788708-2ECBB90A-0333-4A4C-9508-D5245F396034Q33788714-32B8829E-E906-4299-B54F-EDD152AC47BDQ33969418-80E02C48-7902-4BCC-9D65-D64B345F6ED4Q34049089-FCB72E82-A283-44AD-9502-62BE456220E3Q34068968-E5FC6A30-4487-4919-99E7-BCBCFCB34E7AQ34075026-F7A62779-5C3C-454C-9433-30CD6BBD4949Q34245259-13EDD4E2-C62A-4549-AE33-576DBD5E5920Q34411804-A55AC504-7079-4CC6-837A-0EF6F6A02766Q34511192-B9FFBA00-2E7A-458B-968E-08659B2FE395Q34552044-EF3331B8-B53A-495D-A4D0-67B5B0831658Q34636707-E04E2383-D497-4744-BFC9-82F23C172736Q34725972-2B38AD36-570E-4F6B-946D-95D50CC5653CQ34912136-102B4085-8454-4624-BC66-A01D5B81C233Q35094952-3BFA69B8-158E-411F-8263-4E70327E1F14Q35300647-348CB48B-41AF-41C5-AE22-16511488C84EQ35552475-65BFBF04-E78E-4387-B48D-2FB4E806FB82
P2860
The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains
description
1991 nî lūn-bûn
@nan
1991 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
The cytoplasmic region of the ...... tive growth-regulatory domains
@ast
The cytoplasmic region of the ...... tive growth-regulatory domains
@en
The cytoplasmic region of the ...... tive growth-regulatory domains
@en-gb
The cytoplasmic region of the ...... tive growth-regulatory domains
@nl
type
label
The cytoplasmic region of the ...... tive growth-regulatory domains
@ast
The cytoplasmic region of the ...... tive growth-regulatory domains
@en
The cytoplasmic region of the ...... tive growth-regulatory domains
@en-gb
The cytoplasmic region of the ...... tive growth-regulatory domains
@nl
prefLabel
The cytoplasmic region of the ...... tive growth-regulatory domains
@ast
The cytoplasmic region of the ...... tive growth-regulatory domains
@en
The cytoplasmic region of the ...... tive growth-regulatory domains
@en-gb
The cytoplasmic region of the ...... tive growth-regulatory domains
@nl
P2093
P2860
P356
P1476
The cytoplasmic region of the ...... tive growth-regulatory domains
@en
P2093
A D D'Andrea
A Yoshimura
H Youssoufian
P2860
P304
P356
10.1128/MCB.11.4.1980
P407
P577
1991-04-01T00:00:00Z